This list will grow almost daily as new clinical trial results are made known and as new treatment providers emerge.
Please note:
1. It is our job to find you the most experienced and skilled provider, regardless of where they are practicing.
2. If the condition that is of interest to you is not listed above, please still contact us as we are discovering new providers frequently.
Welcome to Stem Cells 21- Regenerative medicine in the 21st Century
Stem Cells 21 delivers to patients suffering from a wide range of chronic and debilitating diseases the realistic hope of improvement using carefully selected stem cell providers in a variety of locations.
Stem cells 21 only refers patients to providers who have:
Developed patient specific treatment protocols.
Proven that they collaborate with the most reliable and reputable biotech companies who adhere to all regulations.
A code of ethics.
Developed procedures that certify stem cells free of infectous diseases.
Consistently used cells that have been third party tested for cell type, count, viability, purity, etc.
Supported pre-clinical and clinical research and who have treated 100's of patients.
A follow up programme that monitors and enhances the effects of stem cell therapy.
Stem cell therapies have been used for decades in the treatment of leukaemia. They now form a mainstream medical approach to the treatment of chronic and debilitating diseases that affect millions of people around the world causing great distress, loss of mobility and negatively impacting on one's quality of life.
Right now help is available for an ever-increasing number of diseases. Patients are finding that they can have their quality of life back and regain all that they thought they had lost. Delaying the progress of a debilitating disease and reducing symptoms has been a huge boon to many, many people who had previously thought they had no options.
Stem cell companies use cells from a variety of sources, such as bone marrow, cord blood, adipose tissue, peripheral blood etc. Embryonic stem cells are not used. Sometimes repeat treatments may be necessary - this will be determined in consultation with the medical practitioner.
StemCells21 only uses companies who have a dedicated counsellor whose job it is to guide patients with sensitivity, knowledge and compassion. Hope not hype is a critical concern for us. We are not salespersons but guides. We research companies and know what treatments are available in this rapidly expanding age of advanced biotechnology.
Diseases & Injuries Stem Cell Research Has the Potential to Impact:
Neurological: Autism, Parkinson's disease, Spinal cord injury (paralysis), Retinal disease, Multiple sclerosis, Neuroblastoma, Lou Gehrig's disease, Muscular Dystrophy, Huntington's disease, Spinal muscular atrophy. Blood: Childhood and adult leukemia, Sickle-cell anemia, Immunodeficiency, Lymphomas, Hodgkin's disease, Lupus, Bone marrow failure. Pancreatic & Blood: Type 1 Diabetes, Type 2 Diabetes. Other: Burns, Ovarian cancer, Heart muscle loss following heart attack, Aneurysms, Breast cancer, Liver disease including hepatitis, Sports injuries, Bone injuries, Hearing disorders, AIDS, Stroke, Renal Disease, Erectile dysfunction, Cardiovascular diseases, PAD, Inflammatory Bowel Disease, Anti-aging, Arthritis.
Autologous:
The source of stem cells used varies from practitioner to practitioner and the research and development companies each clinician uses. This can change in the light of new research findings and the demonstrated effectiveness as evidenced by clinical trial results.
Most use stem cells are from cord blood, fetal stem cells, bone marrow and peripheral blood. Where the patient themselves is the donor it is called an autologous transplant. There is no risk of rejection in these procedures as the DNA is the same. We do not sanction the use of embryonic stem cells which involve the destruction of a human life. It is a fact that to date embryonic stem cells have only caused tumors in rats – they have not been used on humans.
The advances with adult stem cells are happening so quickly that the scientific community is rushing to keep up, and they aren't the only ones! There were so many breakthroughs in the first six months of 2008 that FRC is releasing a special January-June......
By Deborah Halber, General Science / Biology (PhysOrg.com) -- A researcher at MIT’s Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer.....
July 21 2008 WASHINGTON, DC, Jul 19, 2008 (MARKET WIRE via COMTEX) -- Speaking at the 16th Annual World Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies at the Gaylord National Resort in Washington, DC, on Friday, July 18...
July 20, 2008 (HealthDay News) -- Treatment with adult stem cells harvested from blood or bone marrow may benefit some patients with certain kinds of cardiovascular disorders and autoimmune diseases, a new U.S. analysis shows.
Stem cells are cells found in most, if not all, multi-cellular organisms. They are characterized by the ability to renew themselves through mitotic cell division and differentiating into a diverse range of specialized cell types. Research in the stem cell field grew out of findings by Canadian scientists Ernest McCulloch and James Till in the 1960s. The two broad types of mammalian stem cells are: Embryonic stem cells that are found in blastocysts, and adult stem cells that are found in adult tissues. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing specialized cells, but also maintain the normal turnover of regenerative organs, such as blood, skin or intestinal tissues.
As stem cells can be grown and transformed into specialized cells with characteristics consistent with cells of various tissues such as muscles or nerves through cell culture, their use in medical treatments is now available. In particular, autologus stem cells, and highly plastic adult stem cells from the umbilical cord blood cells or bone marrow cells are the promising candidates. Much work is being done on peripheral blood, adipose stem cells, menstrual blood stem cells, nasal cells, teeth etc etc. Every day Google alerts will show promising research in a wide variety of areas and for an ever-expanding group of diseases.